Synergy Healthcare could regain its upward trend after having ran out of steam.

According to Surperformance ratings, the group has strong fundamentals. Sales are in a growth momentum. In fact, 2014 revenues are expected to rise of 8% compared to the last exercise. Moreover, the company is increasing its profitability as net margin is expected to grow of 8% by 2015 reaching an interesting level for the sector. Furthermore, the group’s financial situation has been improved. Thus, leverage has been reduced and should come to 1.44 at the end of the 2014 fiscal year.

Synergy Healthcare stock shows a bullish configuration in the long term, but a correction phase has brought the share to an interesting level. After this strong movement, prices have stabilized near GBp 1221 and a rebound towards GBP 1304 could soon begin.

Consequently, most active investors could take a long position at the current price targeting a return to GBp 1304. A stop-loss order will be placed above the GBp 1197 support in case of a renewal of the correction movement.